Cell And Gene Articles, App Notes, Case Studies, & White Papers

  1. Optimizing Kinetics Assays To Avoid Avidity Effects 1/31/2024

    Considering affinity and avidity early in assay design can ensure the desired assay parameters are achieved. Learn about affinity and avidity and how to recognize and resolve issues that may arise.

  2. EMA Support For Rare Disease Therapies 6/10/2025

    Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.

  3. Using Automated Spinoculation For CAR T Cell Lentiviral Transduction 2/26/2024

    There is a growing demand for closed and automated lentiviral transduction steps in CAR T cell therapy workflows. Learn about a potential solution to address this unmet need.

  4. Standardizing Cryopreservation For Cell Therapy Supply Chains 6/3/2025

    Explore how a standardized cryopreservation process is transforming leukapheresis handling by reducing risk and improving quality across the cell therapy supply chain.

  5. Accelerate Process Development With Automated Aseptic Sampling 5/6/2024

    Discover how implementing automated sampling systems enabled Takeda Pharmaceuticals to achieve new efficiencies in process development.

  6. 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay 9/18/2024

    Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

  7. Amino Acid Analysis Indicates Metabolic Differences In MCB CAR T-Cells 7/26/2024

    Exploring the metabolic differences in CAR T-cells activated with multi-cytokine backpacks (MCBs) reveals correlations between CAR T-cell activation, nutrient metabolism, and efficacy.

  8. Engineering The Future Of Lipsomal Drug Delivery 5/14/2025

    Explore our full collection of case studies to discover how liposome technology is transforming drug delivery across a wide range of therapies.

  9. A Novel Approach To Improving AAV Titers 4/8/2025

    As demand for AAV-based therapies rises, optimizing production processes is essential. By utilizing existing technologies, tailored platforms, and optimized formulations, titers and productivity can be enhanced.

  10. Creating A Sustainable Business Model For Cell And Gene Therapies 10/5/2023

    Avoid product launch delays and expand patient access to CGTs by understanding and meeting regulatory guidelines and securing approval for reimbursement of treatment costs.